21/04/2017 12:20:00

Participate in our $3 million Private Placement to Earn a Potential 20% Return on Investment in THC Therapeutics (THCT) Stock

LAS VEGAS, April 21, 2017 (GLOBE NEWSWIRE) -- THC Therapeutics (THCT) is offering a Reg D private placement to accredited investors, through which we will raise up to $3,000,000. Proceeds from this offering will start the process for THC Therapeutics to become a fully reporting company to the SEC. 50% of the money raised will go towards mergers and acquisitions, the other half will go toward general business operating expenses. This offering will be good for our company, current shareholders and new investors. An example of the terms is as follows, for a $100,000 investment in this private placement, the investor will receive $120,000 of common stock 1 year from the date of investment. The price per share will be determined by the market value at the time the common stock will be issued. This correlates to a 20% return on investment. Minimum investment is $25,000. Prior to investing, all investors must verify their accredited status. No offering is made to any person who does not meet the definition of an accredited investor under Rule 501(a). Further information is contained in our private placement memorandum, which should be reviewed in full before making a decision to invest.

Visit our website to participate in THC Therapeutics Private Placement. (http://thctherapeutics.com/)

Comments from Brandon Romanek, Founder & CEO, “Because of my vast experience as a trader, investor and portfolio manager, I have come up with a creative strategy where one can make a potential 20% return on investment. This will be great for THC Therapeutics, our current shareholders and investors in this offering. I am not willing to sell shares at a discount in an offering like this anywhere near our current stock price. Most of these types of offerings are priced below market value. Investors would have to hold for one year and this could present substantial risk to the investor. That structure does not work at all for THC Therapeutics. When a company does that, it makes a statement of what they believe their current stock price should be and that they’re willing to raise money at a significant discount to market. I am now in the process of returning 1.8 Million shares of my stock in THCT back into the company’s treasury. I am doing this to limit any dilution that can occur with this offering. I’d be happy to personally answer any questions regarding this private placement. Please call or email me directly at Brandon@thctherapeutics.com. I would like to thank everyone for believing in my vision and I promise to do whatever it takes to make THC Therapeutics a premier Health and Healing Cannabis company.”

About THC Therapeutics:

THC Therapeutics is a forward-thinking publicly traded health and healing company in the cannabis industry that has "Better Health through the Science of Nature" as their mission statement. The company is dedicated to innovating new methods and refining current industry standards in the cannabis market. THC Therapeutics' plans for future growth include cultivation, dispensing, extractions, edibles, personal wellness centers and flotation therapy. For more information, visit THCTherapeutics.com.

Forward-Looking Statements Disclosure:

This press release may contain "forward-looking statements" within the meaning of the federal securities laws. In this context, forward-looking statements may address the Company's expected future business and financial performance, and often contain words such as "anticipates," "beliefs," "estimates," "expects," "intends," "plans," "seeks," "will," and other terms with similar meaning. These forward-looking statements by their nature address matters that are, to different degrees, uncertain. Although the Company believes that the assumptions upon which its forward-looking statements based are reasonable, it can provide no assurances that these assumptions will prove to be correct. All forward-looking statements in this press release are expressly qualified by such cautionary statements, risk, and uncertainties, and by reference to the underlying assumptions.

Phone: 702.602.THCC (8422)

Follow Brandon Romanek on Twitter:

Twitter @BrandonRomanek

Follow THC Therapeutics on Facebook and Twitter:

Twitter @THCTherapeutics

Facebook @THCTherapies

Primary Logo

Post comment

Related debate

  • 1 week
  • 1 month
  • 1 Year
22 Jun
I:SP500
  Hejsa alle sammen   Konjunktur: Ifølge vedlagte teoretiske model omkring de ledende indikatorer be..
48
20 Jun
GEN
Et gammelt indlæg:   Hvis man kigger lidt tilbage i tiden og ser på de kvartalsvise resultater, så l..
36
18 Jun
PNDORA
              Jeg har lavet en fuld analyse på Pandora, som er en blanding af en regnskabs-analyse o..
17
20 Jun
GEN
Hold da kæft, du er godt nok en sur (gammel ?) mand......
16
06:55
VWS
Så vidt jeg kan se. har ingen andre i forumet kommenteret Makes ret opsigtsvækkende revurdering af u..
15
23 Jun
 
USA blev løftet ud af recession under Obama. Punktum. Økonomien kørte fint da Trump blev valgt og er..
12
19 Jun
VWS
https://www.vestas.com/en/media/company-news?n=1763161#!NewsView
12
19 Jun
I:SP500
Trump har bedt det amerikanske handelsministerie om en liste over kinesiske varer for 200 mia USD, s..
12
18 Jun
BAVA
Dvs de bør være der indenfor 9 børsdage... Hvis disse data gentager det som er kommet frem indtil nu..
12
20 Jun
NOVO-B
Oral semaglutid viser statistisk signifikant større reduktioner i langtidsblodsukker og vægt sammenl..
11

HSBC Bank Plc : Form 8.5 (EPT/RI) - Lonmin PLC

22/02/2018 10:54:53
FORM 8.5 EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the "Code") 1.         KEY INFORMATION (a) Name of exempt principal trader: HSBC BANK PLC (b) Name of offeror/offeree i..

Rathbone Brothers Plc : Preliminary announcement of 2017 results

22/02/2018 07:00:19
Funds under management up 14.3% to £39.1 billionThis is a preliminary statement of annual results published in accordance with FCA Listing Rule 9.7A. It covers the year ended 31 December 2017. Mark Nicholls, Chairman of Rathbone Brothers Plc, said: "UK and global investment markets performed well in 2017, with some indices reaching record levels towards the end of the year. This outcome has b..

Elliott Capital Advisors, L.P : Form 8.3 - GKN Plc

Related news
21/02/2018 15:25:10
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the "Code") 1.         KEY INFORMATION (a) Full name of discloser: Elliott Capital Advisors, L.P. (for itself and related general partners ..

Most read news

  • 24 hours
  • 48 hours
  • 1 week
1
Lexicon Pharmaceuticals Announces Positive 52-Week Results From Sotagliflozin inTandem2 Study Presented at ADA 2018 and Published in Diabetes Care
2
Larson Electronics LLC Releases Combination White and Green LED Light Bar
3
Larson Electronics LLC Releases Explosion Proof Emergency LED Exit/KELUAR Sign

Buy and sell signals

  • Trend
  • Moneymachine

Copyright Euroinvestor A/S 2018   Disclaimer and Terms of Use
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
24 June 2018 17:55:19
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20180619.1 - EUROWEB4 - 2018-06-24 18:55:19 - 2018-06-24 17:55:19 - 1000 - Website: OKAY